4//SEC Filing
Williams Richard Thomas 4
Accession 0001209191-23-009205
CIK 0001797768other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:00 PM ET
Size
5.7 KB
Accession
0001209191-23-009205
Insider Transaction Report
Form 4
Williams Richard Thomas
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-10+215,000→ 215,000 totalExercise: $6.78Exp: 2033-02-10→ Common Stock (215,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the total number of shares granted under the Option shall vest and become exercisable starting on March 1, 2023 (the "Vesting Commencement Date") and thereafter each month on the same day of the month as the Vesting Commencement Date, until all shares subject to the Option have vested on February 1, 2027, subject to the Reporting Person continuing to be a service provider through each such date.
Documents
Issuer
Kinnate Biopharma Inc.
CIK 0001797768
Entity typeother
Related Parties
1- filerCIK 0001825148
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:00 PM ET
- Size
- 5.7 KB